For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top
Open Access
- 30 April 2012
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 18 (9) , 2417-2419
Abstract
The stromal immunoglobulin kappa chain (IGKC) has been validated as an immunologic biomarker of prognosis and response to therapy in human breast cancer and other cancers. This validation emphasizes the key role of humoral immunity in control of cancer progression and has major implications for determining prognosis of patients with cancer. Clin Cancer Res; 18(9); 2417–9. ©2012 AACR.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- The immune score as a new possible approach for the classification of cancerJournal of Translational Medicine, 2012
- Cancer vaccines inducing antibody production: more pros than consExpert Review of Vaccines, 2011
- The prognostic significance of B lymphocytes in invasive carcinoma of the breastBreast Cancer Research and Treatment, 2011
- Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune ReactionJournal of Clinical Oncology, 2011
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast CancerCancer Research, 2008
- Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody TherapiesCancer Research, 2007
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the BreastThe Journal of Immunology, 2002
- The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cellsProceedings of the National Academy of Sciences, 2001
- Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breastBreast Cancer Research and Treatment, 1986